---
title: CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in
  tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring
  dynamic loss of CD123
date: '2024-03-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38492495/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240317180542&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: No ...
disable_comments: true
---
No ...